Clinical Trials Logo

Gut Hormones clinical trials

View clinical trials related to Gut Hormones.

Filter by:
  • None
  • Page 1

NCT ID: NCT05306678 Completed - Metabolic Health Clinical Trials

Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults

Start date: December 29, 2020
Phase: N/A
Study type: Interventional

The purpose of this project is to investigate the effects of breaking up prolonged sitting on postprandial metabolic responses, gut hormones secretion and energy balance in sedentary overweight and obese adults.

NCT ID: NCT05306613 Completed - Metabolic Health Clinical Trials

Breaking Sitting and Metabolic Health in Sedentary Lean Adults

Start date: December 30, 2020
Phase: N/A
Study type: Interventional

The purpose of this project is to investigate the effects of breaking up prolonged sitting on postprandial metabolic responses, gut hormones secretion and energy balance in sedentary lean adults.

NCT ID: NCT04452786 Withdrawn - Clinical trials for Glucose Metabolism Disorders

Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty

Start date: June 5, 2020
Phase: N/A
Study type: Interventional

The investigators of the study want to investigate the complex interactions between glucose metabolism, food intake/weight loss, and different appetite regulating hormones after ESG in comparison with conventional laparoscopic sleeve gastrectomy (LSG).

NCT ID: NCT04082923 Completed - Obesity Clinical Trials

Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery

Obesity
Start date: October 3, 2019
Phase: N/A
Study type: Interventional

The investigators want to evaluate the difference in glucose metabolism and intestinal hormonal response after a liquid meal versus a solid meal in patients after bariatric surgery.

NCT ID: NCT04031222 Completed - Obesity Clinical Trials

Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes

MI4D
Start date: May 19, 2017
Phase:
Study type: Observational

This study intends to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.

NCT ID: NCT03701503 Completed - Obesity Clinical Trials

The Comparison of PYY, Ghrelin, GLP1, Glucose Level, Level of Satiety, and Ad Libitum Intake in Obese and Non-Obese Patients After Breakfast With Balanced Macronutrient Composition

Start date: October 2010
Phase: N/A
Study type: Interventional

Obesity can occur due to an imbalance of energy. This energy balance is greatly influenced by hunger and satiety. Obese person cannot resist hunger, while non obese can control hunger. Gut hormones, such as PYY and ghrelin, are associated with appetite and satiety control. This study's objective is to compare the effect of breakfast with balance composition on gut hormones, glucose and ad libitum intake four hours after breakfast between obese and non obese.. The research methodology was used a clinical trial with 18 obese women and 22 non obese women participants. Subjects were given a balance breakfast (protein 12,4%, carbohydrate 68,2%, fat 22,6%). Gut hormones (PYY, Ghrelin, GLP -1) level , Glucose level and satiety level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.

NCT ID: NCT03697486 Completed - Obesity Clinical Trials

The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women

Start date: October 2010
Phase: N/A
Study type: Interventional

Gut hormones, such as PYY and ghrelin, are associated with appetite control and obesity. Protein is thought to be the most satieting nutrient and could affect production of several gut hormones. This study's objective is to find the effect of breakfast with different protein composition on PYY, ghrelin, and ad libitum intake four hours after breakfast. The research methodology was used a clinical trial with 22 obese women participants. Subjects were given three types of breakfast: low protein consumption (12.4% protein), medium protein (23.5% protein), and high protein (40,6% protein). PYY and ghrelin level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.

NCT ID: NCT03223389 Not yet recruiting - Type 2 Diabetes Clinical Trials

Fat Metabolites and Gut Hormones

Start date: August 7, 2017
Phase: N/A
Study type: Interventional

To investigate the effects of different fat metabolites on gut hormone secretion in gastric bypass operated subjects and BMI-matched controls.